10-Q: Global Innovative Platforms Reports Continued Losses in Q3 2024, Raises Going Concern Doubt

Global Innovative Platforms, Inc. reports ongoing losses and dependence on external funding, raising concerns about its ability to continue as a going concern.

Summary

• Global Innovative Platforms, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2024.
• The company is in the business of measuring gas outflow in pets and agriculture for diagnosis and treatment of illness.
• The company incurred a net loss of $59,715 for the nine months ended June 30, 2024, and had a retained deficit of $460,721 as of June 30, 2024.
• The company had no revenue for the three and nine months ended June 30, 2024.
• General and administrative expenses were $6,360 for the three months ended June 30, 2024, and $59,715 for the nine months ended June 30, 2024.
• As of June 30, 2024, the company had cash and cash equivalents of $10,146 and total liabilities of $216,897.
• The company's independent registered public accounting firm's report includes a going concern explanatory paragraph.
• The company's plan of operation is to obtain debt or equity finance to meet ongoing operating expenses and opportunities for growth.
• The company issued 24,531,027 shares of common stock at $0.0001 per share on October 23, 2023.
• The company issued 2,160,000 shares of common stock in conversion of a $216,000 debenture on October 23, 2023.
• On July 12, 2024, the company issued 530,000 shares of common stock for services and 1,111 shares for cash to correct an administrative error.

Sentiment

Score: 2

Explanation: The document paints a negative picture due to the company's ongoing losses, lack of revenue, going concern warning, and dependence on external funding. The sentiment is very low due to the significant financial challenges and uncertainties surrounding the company's future.

Positives

• Cash and cash equivalents increased from $415 to $10,146 between September 30, 2023 and June 30, 2024.
• General and administrative expenses decreased from $158,686 to $59,715 for the nine months ended June 30, 2023 and 2024 respectively.

Negatives

• The company has a retained deficit of $460,721 as of June 30, 2024.
• The company has no revenue for the three and nine months ended June 30, 2024.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• The company has total liabilities of $216,897 as of June 30, 2024.

Risks

• The company's ability to continue as a going concern is dependent on raising additional debt or equity funding.
• There is no assurance that the company will be able to raise the necessary equity and/or debt to fund its ongoing operating expenses.
• Future losses are likely to occur until the company is able to fund its business plan and pursue opportunities for growth.
• The company lacks a sufficient complement of personnel with accounting expertise and an adequate supervisory review structure.
• There is inadequate segregation of duties due to the limitation on the number of accounting personnel.
• The company has insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets used for financial reporting.

Future Outlook

The company plans to obtain debt or equity finance to meet ongoing operating expenses and opportunities for growth in return for shares of its common stock to create value for its shareholders.

Management Comments

• The company will need substantial additional capital to support its budget.
• In the event funds cannot be raised when needed, the company may not be able to carry out its business plan, may never achieve sales or royalty income, and could fail in business as a result of these uncertainties.

Industry Context

The company operates in the niche market of measuring gas outflow in pets and agriculture for diagnosis and treatment of illness, which may have limited market size and potential for growth compared to broader healthcare or agricultural technology sectors.

Comparison to Industry Standards

• Given the lack of revenue and the going concern warning, Global Innovative Platforms is significantly underperforming compared to established companies in related fields such as animal diagnostics or agricultural technology.
• Companies like Zoetis (animal health) or Deere & Company (agricultural technology) have substantial revenues, profits, and established market positions, which contrasts sharply with Global Innovative Platforms' current financial state.
• Without specific comparible companies or projects, it is difficult to compare the results to global benchmarks.

Management Changes

Legal Proceedings

• The company was not subject to any legal proceedings during the nine months ended June 30, 2024, and, to the best of our knowledge, no legal proceedings are pending or threatened.

Related Party Transactions

• As of June 30, 2024 and September 30, 2023, the company owed $100,000, $50,000, and $47,863 ($36,363 at September 30, 2023) to principal shareholders (plus an additional $175,000 that was owed to a shareholder on September 30, 2023 but converted to common stock in October, 2023).
• The loans are unsecured, interest free and due on demand.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and potential inability to continue as a going concern.
• Employees' job security is uncertain due to the company's financial challenges.
• The company's ability to fulfill its obligations to suppliers and creditors is questionable given its limited financial resources.

Next Steps

• The company intends to seek debt and/or equity financing to meet ongoing operating expenses and develop its operations.
• The company will pursue opportunities for growth in return for shares of its common stock to create value for its shareholders.

Key Dates

Keywords

financial statements, going concern, net loss, common stock, operating expenses, debt financing, equity financing, liabilities, assets, revenue